Welcome to the Abstract Submission Portal of ILCA Annual Conference 2021
Abstracts should address aspects of liver cancer focusing on all aspects of this disease with a clear emphasis on maximizing focus, exchange, and results.
All entries should fall under one of the below categories:
1. Molecular Pathogenesis, Cell Biology and Translational Research
2. Epidemiology, Staging and Prognosis
3. Diagnosis, Imaging and Biomarkers
4. Therapy & Miscellaneous
5. Clinical Trials in progress
We are looking forward to your inspiring contributions!
Abstracts can be submitted until 6 April 2021 at 23:00 (UTC+1). Submissions after this deadline will not be possible, unless ILCA extends the new submission deadline date. In that case, the new submission deadline will be clearly communicated to the submitters via the conference website.
Abstracts can only be submitted electronically through the abstract submission portal.
Upon submission, abstract submitters will receive confirmation of submission by e-mail. Lack of confirmation email indicates that the abstract was not correctly submitted.
Notification on the outcome of the abstract submission will be sent by email to the submitting author by mid-May 2021.
If the presenting author is unable to present the abstract, one of the co-authors can present in his/her place. An email from the presenting author indicating the change is requested and must be received by the ILCA Office by latest 1 July 2021 (UTC+1). The presenting author or at least one of the abstract co-authors should plan to register and attend the ILCA Annual Conference 2021.